ClinicalTrials.gg
Not yet recruitingNCT07677748OPTIMMUSICUpdated Jul 1, 2026

Optimization of Perceived Sound Quality for Music Listening in Hearing Aid Users With Hearing Loss.

An observational study in Hearing Impaired (Partially), sponsored by Institut Pasteur. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Institut Pasteur · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
66
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to optimize music listening quality for 66 hearing aid users (33 musicians and 33 non-musician music enthusiasts) by developing a dedicated "Music Program" based on individual frequency preference profiles. We will evaluate the program's efficacy by comparing listening quality and emotional response scores against standard settings, while also investigating correlations with music reward sensitivity. We hypothesize that the customized program will yield significant improvements, with a more pronounced benefit observed in the musician group.

02

Conditions studied

  • Hearing Impaired (Partially)

Browse trials for

03

In context

Hearing Loss

796 studies on the registry are indexed under Hearing Loss; 193 are open to participants now.

This study's planned enrollment of 66 is below the median of 100 across 192 observational studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Institut Pasteur is the lead sponsor of 99 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hearing-impaired musicians or music enthusiasts who have been using hearing aids for at least 6 months.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For all participants:

  • Aged 18 years or older,
  • Fitted with hearing aids for at least 6 months,
  • Reporting dissatisfaction with music listening while using their hearing aids.

For musician participants:

  • Defined as instrumentalists or knowledgeable music enthusiasts engaging in daily music practice for a minimum of 4 hours.

For non-musician participants:

  • Defined as individuals without formal musical training who listen to music for at least one hour per day

Exclusion criteria

Exclusion Criteria:

  • Asymmetric hearing loss (pure-tone audiometry showing a difference between the two ears > 15 dB)
  • Irregular use of hearing aids: \< 4 hours per day
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
66 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hearing-impaired musicians

    Other: Musical listening quality preference test

  • music enthusiasts who have been using hearing aids

    Other: Musical listening quality preference test

Interventions

  • OtherMusical listening quality preference test

    Preference test to determine their Preferred Frequency Profile (PFP). The gain characteristics of the PFP will be added to the hearing aids' Main Program, thereby creating a dedicated Music Program.

06

What researchers measure

Primary outcomes

  1. Comparison of scores obtained using the Davies-Venn validated quality ranking questionnaire between the Main Program and the Music Program.

    scale from 0 (bad listening quality) to 10 (best listening quality)

    Time frame: for 4 months

Secondary outcomes

  1. Comparison of listening improvement scores on the Davies-Venn validated quality ranking questionnaire between hearing aid users categorized as "musicians" and "non-musicians."

    scale from 0 (bad listening quality) to 10 (best listening quality)

    Time frame: for 4 months

  2. Comparison of Filtering Patterns (PFP) obtained during the preference test between Session 1 and Session 2 for the same musical excerpt.

    Time frame: for 4 months

  3. Comparison of Filtering Patterns across two musical excerpts of different styles.

    Time frame: Day 2

  4. Comparison of scores on the Davies-Venn validated quality ranking questionnaire between two musical excerpts of different styles.

    scale from 0 (bad listening quality) to 10 (best listening quality)

    Time frame: Day 2

  5. Determination of a correlation between the improvement associated with the Music Program and Barcelona Music Reward Questionnaire (BMRQ) scores, analyzed separately for musicians and non-musicians.

    Time frame: for 4 months

  6. Comparison of emotional listening quality scores between the Main Program and the Music Program.

    Time frame: for 4 months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for May 2028, 20 months later.

Of 98 observational studies under Hearing Loss, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 83. This study's planned 20 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2026
First posted
Jul 1, 2026
StartEst.
Sep 2026
Primary completionEst.
May 2028
CompletionEst.
May 2028
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07677748
Lead sponsor
Institut Pasteur
Responsible party
Sponsor
First posted
Jul 1, 2026
Start date
Sep 2026 (estimated)
Primary completion
May 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Jul 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion